Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve the Audited financial result ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Trident Texofab Ltd has informed BSE that its Board of Directors will meet on Thursday, May 29, 2025, at the registered office in Surat. The main agenda is to consider and approve the audited standalone financial results for the quarter and financial year ended March 31, 2025. The company has also mentioned that any other business may be taken up with the Chair's permission. In line with insider trading rules, the trading window for the company's equity shares has been closed since April 1, 2025, and will reopen 48 hours after the results are made public on May 29, 2025.
This is a routine advance notice of the board meeting where FY25 audited results will be approved; no actual financial numbers have been disclosed yet, so there is no immediate impact on shareholders or the stock price from this filing alone.